(Q44541929)

4 December 2017

title

Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum (English)

1 reference

4 December 2017

0 references

1 reference

2

1 reference

4 December 2017

Mustafa Sarsilmaz

1

1 reference

4 December 2017

Hüseyin Ozyurt

3

1 reference

4 December 2017

Ilter Kuş

4

1 reference

4 December 2017

Oğuz Aslan Ozen

5

1 reference

4 December 2017

Birsen Ozyurt

6

1 reference

4 December 2017

Sadik Söğüt

7

1 reference

4 December 2017

Omer Akyol

8

1 reference

4 December 2017

publication date

1 October 2003

1 reference

Prostaglandins, Leukotrienes and Essential Fatty Acids

4 December 2017

published in

1 reference

4 December 2017

volume

69

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

253-259

1 reference

Biochemical effects of a diet containing foods enriched with n-3 fatty acids

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Do essential fatty acids play a role in brain and behavioral development?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Is There a Rational Use for n-3 Fatty Acids (Fish Oils) in Clinical Medicine?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Reactive oxygen species and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Arachidonic Acid: A Common Link in the Biology of Schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Elevated plasma lipid peroxides at the onset of nonaffective psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Malignant transformation-linked imbalance: Decreased xanthine oxidase activity in hepatomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Studies on dopaminergic and GABAergic markers in striatum reveals a decrease in the dopamine transporter in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Activities of free radical and DNA turn-over enzymes in cancerous and non-cancerous human brain tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Gases as biological messengers: nitric oxide and carbon monoxide in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Schizophrenia: the illness that made us human

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment With Eicosapentaenoic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2803%2900107-8

7 January 2021

10.1016/S0952-3278(03)00107-8

Identifiers

DOI

1 reference

4 December 2017

1 reference